in talks to hire Perrigo's Papa as CEO: source
Send a link to a friend
[April 22, 2016]
By Carl O'Donnell
(Reuters) - Drugmaker Valeant
Pharmaceuticals International Inc <VRX.TO> is seeking to appoint Perrigo
Co Plc's <PRGO.N> boss Joseph Papa as its new chief executive, a source
familiar with the matter said.
The Canadian drugmaker is negotiating a contract with the Perrigo
CEO and it aims to announce his appointment as soon as next week,
the source told Reuters.
However, Perrigo board has not said whether it would allow Papa to
void a non-compete clause in his contract, the source said.
Valeant declined to comment on the "rumors." A call to Perrigo's
media contact was not immediately returned.
The Wall Street Journal earlier reported that Valeant was looking to
name Papa as next CEO.
Valeant said in March CEO Michael Pearson was leaving the company,
just three weeks after returning from a two-month medical leave. The
company said at that time Pearson would remain in his post until it
finds his successor.
Debt-laden Valeant has recently settled with some of its lenders
after a missed deadline for filing its annual report put the company
at risk of a default. It secured an extension until May 31, but has
pledged to file its statements toward the end of April.
[to top of second column]
Reuters reported last week Valeant had brought in investment banks
to review its options amid interest from buyout firms and other
companies in its businesses.
Pearson and activist investor William Ackman, who joined Valeant's
board last month, have said Valeant was considering selling non-core
assets to help cut its $30 billion debt pile.
(Additional reporting by Rama Venkat Raman in Bengaluru; Editing by
[© 2016 Thomson Reuters. All rights
Copyright 2016 Reuters. All rights
reserved. This material may not be published, broadcast, rewritten